Results 141 to 150 of about 13,518 (258)

Board-certified psychiatric pharmacists in substance use disorder treatment: Integration, services, and outcomes across care settings. [PDF]

Ment Health Clin
Vallabh A, Abelleira A, Douglass AR, Gutierrez CA, Maister A, Miskle B, Moeller KE, Salwan A, Waters K, Dadiomov D.   +9 more
europepmc   +1 more source

The psychometric properties of validated tools to assess cannabis use disorder: A systematic review and meta‐analysis

Addiction, EarlyView.
Abstract Aims To systematically review the evidence on the psychometric performance and accuracy of screening or diagnostic tools for cannabis use disorder. Method Systematic review and meta‐analysis which included studies conducted in clinical settings, schools, universities, community settings and population‐based surveys in multiple countries and ...
Janni Leung, Daniel Stjepanovic, Stephanie Fong, Danielle Dawson, Giang Vu, Tesfa Yimer, Caitlin McClure‐Thomas, Wayne Denis Hall, Gary Chung Kai Chan   +8 more
wiley   +1 more source

Factors associated with emotional regulation self-efficacy in adolescents hospitalized for intentional drug and chemical overdose: a cross-sectional study. [PDF]

Front Psychiatry
Li T, Chen N, Zhang S, Zhao S, Zhao L.
europepmc   +1 more source

The feasibility of mindfulness‐based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Mindfulness‐based relapse prevention (MBRP) has been shown to be beneficial to individuals with substance use disorder (SUD) in the West. The current pilot study aimed at testing the feasibility of MBRP in a Chinese population.
Ka Tsun Ting, Ivan Chun Him Leung, Dicken Cheong Chun Chan, Ken On Tai Yu, Wai Kwong Tang, Fu Chan, Alan Ka Lam Tang, Helen Shuk Wah Ma, Benjamin Hon Kei Yip, Daisy Dexing Zhang, Sarah Bowen, Samuel Yeung Shan Wong   +11 more
wiley   +1 more source

India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics. [PDF]

Indian J Psychol Med
Tom A, Reddy BSC, Sethi MIS, Math SB.
europepmc   +1 more source

Substance‐related intrusive memories in cocaine use disorder are different from but associated with craving

Addiction, EarlyView.
Abstract Background and aims Cocaine use disorder (CUD) is a significant global health concern, characterized by persistent craving despite severe consequences. Recent theories highlight maladaptive memory processes – such as intrusive, vivid recollections of past substance use that arise spontaneously in daily life – as key contributors to craving and
Amelie Zacher, Lina Dietiker, Victoria Häffner, Francesco Bavato, Birgit Kleim, Boris B. Quednow   +5 more
wiley   +1 more source

Analysis of the Prevalence of Alcohol and Psychoactive Substances Among Drivers in the Material from the Department of Forensic Medicine at the Medical University of Bialystok in Poland. [PDF]

Toxics
Szeremeta M, Janica J, Jurkiewicz G, Galicka M, Koścień J, Więcko J, Perkowski J, Jeleniewski MK, Siemieniuk K, Niemcunowicz-Janica A.   +9 more
europepmc   +1 more source

‘Emptiness filled with love’: A reflexive thematic analysis of chemsex trajectories among gay, bisexual and other men who have sex with men in Almaty, Kazakhstan, using a life course framework

Addiction, EarlyView.
Abstract Background and aims The intentional use of psychoactive substances to enhance sexual experiences, known as chemsex, is associated with human immunodeficiency virus (HIV) transmission, psychological distress and social isolation among gay, bisexual and other men who have sex with men (GBMSM).
Nikolay Lunchenkov, Nadezhda Cherchenko, Elena German, Susanna Rinne‐Wolf   +3 more
wiley   +1 more source

[Psychotropic substances].

Arquivos brasileiros de cardiologia, 1973
openaire   +1 more source

From knowledge to attitude: design and initial validation of scales for assessing psychoactive substance consumption among university students. [PDF]

Front Public Health
Kfoury R, Salameh P, Peyriere H.
europepmc   +1 more source